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Abstract
Background: Accurate prevalence data on cocaine use, that points to where problems exist and
the extent of these problems, is necessary to guide the formulation of effective substance abuse
policy and practice. The purpose of this study was to provide surveillance information about the
nature and extent of problematic cocaine use in South Africa.
Methods: Data were collected between January 1997 and December 2006 on admissions for drug
abuse treatment through a regular monitoring system involving 56 drug treatment centres and
programmes in Cape Town, Gauteng Province (Johannesburg and Pretoria) and the Eastern Cape
every six months as part of the South African Community Epidemiology Network on Drug Use
(SACENDU). A one-page form was completed by treatment centre personnel to obtain
demographic data, the patients' primary and secondary substances of abuse, the mode, frequency
and age of first use of substance, and information on prior treatment.
Results: Treatment indicators point to a significant increase in cocaine related admissions over
time in all sites, but with substantial inter-site variation, particularly in recent years. The data
indicate high levels of crack cocaine use and high levels of daily usage among patients, most of whom
were first time admissions. Patients with cocaine related problems continue to be predominantly
male, with a mean age of around 30 years. Substantial changes in the racial profile of patients have
occurred over time. Poly drug use is high with cocaine often used with alcohol, cannabis and other
drugs.
Conclusion: These trends point to the possibility of cocaine use becoming a serious health and
social issue in South Africa and demonstrate the utility of continued monitoring of cocaine
treatment admissions in the future. They also highlight the need to address cocaine use in national
and provincial policy planning and intervention efforts. In terms of treatment, the findings highlight
the need to ensure that treatment practitioners are adequately trained to address stimulant
problems, poly drug use, and HIV and other risk behaviour related to crack cocaine use. Possible
gaps in access to treatment by certain sectors of the population should be addessed as a matter of
urgency.
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Background
According to the European Monitoring Centre for Drugs
and Drug Addiction (EMCDDA), cocaine use is currently
at historically high levels in Europe, with new treatment
admissions for cocaine more than doubling between
1999 and 2005 [1]. In Africa, particularly in countries in
the west and south-east, cocaine use has also increased
[2]. South Africa, one of the largest countries in Africa
with a population of 45 million [3] and a driving force
behind The New Partnership for Africa's Development
(NEPAD) has seen a rapid increase in cocaine, heroin and
amphetamine type stimulant trafficking and use since
independence from white minority rule ('Apartheid') in
1994. This increase has been ascribed to the opening up
of the country's borders, a decrease in very restrictive inter-
nal state controls, high levels of unemployment, and an
increasing use of this country as a route for transshipment
of cocaine from South America to Europe and occasion-
ally North America [4].
In South Africa there have been few national surveys to
assess the extent of cocaine use since 1994. While the
most recent national survey conducted among persons
15 years and older in 2005 found that 0.3% of partici-
pants reported lifetime use of cocaine [5], the Youth Risk
Behaviour Survey conducted in 2002 among students in
grades 8–11 reported a lifetime prevalence of 6.4% [6].
The use of cocaine potentially has important implica-
tions for public health in South Africa with its already
high levels of violent crime and HIV infection [4,7,8].
Accurate prevalence data on cocaine use, that points to
where problems exist and the extent of such problems, is
necessary to guide the formation of effective drug poli-
cies and practices. While national surveys have a number
of advantages, on their own they have significant limita-
tions. These include a limited ability to estimate the
prevalence of less commonly used drugs like cocaine,
especially if sample sizes are small. In contrast, datasets
on treatment admissions are useful for indirectly assess-
ing trends in problematic drug use, and have been used
for this purpose among others in the European Union
and other parts of the world [9-11].
Given reports of the increasing transshipment of cocaine
via Africa to Europe and EMCDDA reports of increasing
numbers of individuals presenting for treatment with
cocaine related problems, our aim was to determine if
treatment admissions for cocaine related problems were
also increasing in South Africa, a country with strong his-
torical and economic ties to countries in the European
Union. Specifically our purpose was to describe trends in
treatment admissions for cocaine related problems in
three sentinel sites in South Africa for the period January
1997 to December 2006 and compare South African find-
ings with the most recent data on cocaine related treat-
ment admissions from the EMCDDA.
Methods
Established in 1996, the South African Community Epi-
demiology Network on Drug Use (SACENDU) is a net-
work of researchers, practitioners and policy makers from
eight sentinel sites in South Africa who meet bi-annually
to provide community-level public health surveillance
information about alcohol and other drug (AOD) trends.
These sites consist of the two port cities of Cape Town and
Durban and six provinces: Gauteng, which includes the
cities of Johannesburg and Pretoria (added in 1998);
Mpumalanga, in the northeast of the country (added in
1999); the Eastern Cape, comprising the urban centres of
Port Elizabeth, East London, Umtata, and surrounding
areas (added in 2004); and the North West, the Northern
Cape and the Free State provinces (all added in 2006).
Together they comprise about 75% of the population of
the country.
The focus of this paper is on data related to cocaine related
problems obtained from specialist AOD treatment centres
in Cape Town, Gauteng and the Eastern Cape. These sites
were chosen as they collectively have the largest number
of treatment centres (56 of the 73 centres participating
across the eight site monitoring system) and account for
roughly 40% of the total population of the country [3].
Currently specialist treatment centres are the main source
of data on cocaine use for SACENDU. Data are currently
collected from all state-funded and most private institu-
tions, including more than 80% of treatment centres in
these sites (28 in Cape Town, 19 in Gauteng, and 9 in the
Eastern Cape) [12,13]. In order to be admitted to alcohol
and other drug treatment centres, patients are generally
required to meet the Diagnostic and Statistical Manual ver-
sion IV (DSM-IV) criteria for substance abuse or substance
dependence.
For the purpose of surveillance, a standardised one-page
form is completed on each person treated by a given cen-
tre during a particular six-month period. The form elicits
responses about the source of referral for treatment,
demographic information, the type of treatment received
(inpatient and/or outpatient), the primary, secondary, ter-
tiary and fourth substance of abuse, the mode(s) of use,
frequency of use, age of first use and whether the person
had received treatment prior to the current episode. The
items included in the form were drawn from items used
by the Pompidou Group in Europe in the mid 1990s and
are similar to items currently included in the EMCDDA's
Treatment Demand Indicator Protocol (TDI) and the US
Treatment Episode Data Set (TEDS) [10,11]. Treatment
centres receive ongoing training in data collection proce-
dures. Typically the form is filled in by the case manager aSubstance Abuse Treatment, Prevention, and Policy 2007, 2:37 http://www.substanceabusepolicy.com/content/2/1/37
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few days after the patient has been admitted to the centre.
To ensure data quality, completed forms are checked for
missing information and possible miscodes. Ethical
approval for the SACENDU project was granted by the
Ethics Committee of the Medical Research Council of
South Africa.
In terms of data analysis, descriptive statistics are reported
together with Cochrane-Armitage tests to assess whether
particular trends are statistically significant.
Results
Data on the proportion of patients having cocaine as a pri-
mary or overall (primary to fourth) drug of abuse across
the three sites is given in Table 1, together with the
Cochrane-Armitage trend test results for each distribution.
The cumulative total number of patients seen at these
AOD treatment centres for any substance of abuse, includ-
ing alcohol, over the 20 data collection periods, was
38,686 in Cape Town (between January 1997 and Decem-
ber 2006), 49,171 in Gauteng (between January 1998 and
December 2006) and 3,939 in the Eastern Cape (between
January 2004 and December 2006). The Cochrane-Armit-
age trend tests revealed that the proportion of patients
reporting cocaine as their primary drug of abuse relative to
other substances, increased significantly in all sites over
time (Table 1).
The trend tests for the proportion of users in each of the
three sites having cocaine as an overall drug of abuse were
also statistically significant. The trend tests, however,
mask the actual distribution of patients that had cocaine
as an overall substance of abuse (Figure 1). For Cape
Town, the graph shows an increase in treatment admis-
sions for cocaine related problems from 1997 until the
second half of 1999, then a decline until the first half of
2002 (with an isolated increase in the first half of 2001),
then an increase until the first half of 2004, after which it
gradually starts to decline. The graph for Gauteng also
shows an increase till the second half of 1999 and then a
decline until the second half of 2003 with steady increases
thereafter. With the exception of the second half of 2005,
the graph for the Eastern Cape has shown a steady
increase in cocaine related treatment admissions since the
start of data collection.
Over time the percentage of crack cocaine use relative to
cocaine hydrochloride (HCL) use has fluctuated between
just over 50% to around 85% in Gauteng and Cape Town
and between 31% and 66% in the Eastern Cape. The ratio
Table 1: Percentage of patients from specialist treatment centres in Cape Town, Gauteng and Eastern Cape with cocaine (HCL/crack) 
as a primary or overall1 drug of abuse, ratio of crack users to total cocaine users as a %, and % of new admissions among patients with 
cocaine as a primary drug of abuse
Cape Town Gauteng Eastern Cape
Users in 
treatment for 
cocaine or crack 
(primary)
% of 
crack to 
total 
cocaine
% of users 
reporting 
cocaine overall1
% new 
adm.3,4
Users in 
treatment for 
cocaine or crack 
(primary)
% of 
crack to 
total 
cocaine
% of users 
reporting 
cocaine overall1
% new 
adm.3,4
Users in 
treatment for 
cocaine or crack 
(primary)
% of 
crack to 
total 
cocaine
% of users 
reporting 
cocaine overall1
% new 
adm.3,4
n% n% n% n% n% n%
1997a 71 3.4 85.9 91 4.3 - - - - - - - - - - - - -
1997b 78 3.6 64.1 117 5.4 - - - - - - - - - - - - -
1998a 131 5.7 78.6 265 11.5 - 157 8.0 52.5 271 12.8 - - - - - - -
1998b 99 7.3 65.7 198 14.5 - 204 8.6 79.6 374 15.8 - - - - - - -
1999a 126 8.3 72.2 168 11.0 - 283 10.3 78.6 453 16.5 - - - - - - -
1999b 137 8.8 70.1 299 19.3 61.3 273 10.5 78.1 491 18.8 - - - - - - -
2000a 132 7.8 65.9 284 16.8 61.2 267 10.6 77.4 430 17.1 - - - - - - -
2000b 121 7.1 67.8 252 14.9 59.5 198 7.5 80.0 383 14.3 59.6 - - - - - -
2001a 144 9.2 68.1 335 21.3 54.8 210 7.4 77.0 466 16.4 - - - - - - -
2001b 88 5.6 73.9 231 14.8 57.5 155 5.8 74.1 386 14.4 52.9 - - - - - -
2002a 106 6.6 52.8 211 13.1 63.2 183 5.2 84.6 429 14.6 59.6 - - - - - -
2002b 104 6.7 58.7 247 15.9 67.0 146 5.6 67.9 355 13.7 54.8 - - - - - -
2003a 136 7.9 72.1 312 18.1 55.9 155 5.9 66.1 381 14.6 51.0 - - - - - -
2003b 139 8.4 66.9 358 21.6 61.6 182 6.8 70.6 394 14.5 56.6 - - - - - -
2004a 219 9.7 65.8 491 21.8 59.4 256 9.1 72.3 507 18.0 69.5 33 5.1 48.5 76 11.6 69.7
2004b 210 9.1 67.1 463 20.1 63.8 263 9.9 68.4 510 19.2 63.1 42 7.0 31.0 82 13.7 47.6
2005a 205 8.3 62.9 475 19.2 69.3 271 9.0 69.0 577 19.0 63.1 73 10.9 65.8 125 18.6 62.5
2005b 163 7.6 69.32 386 18.1 71.1 287 10.1 69.3 574 20.2 71.4 53 9.1 75.52 88 15.0 71.7
2006a 159 6.0 65.42 415 15.6 59.1 345 11.1 71.3 667 21.4 64.1 145 18.4 78.22 218 27.7 63.7
2006b 134 4.8 62.52 346 12.4 57.5 353 10.7 67.1 778 23.6 68.3 124 19.2 83.92 187 29.0 65.3
Trend 
test
Z = 4.461 Z = 15.982 Z = 3.775 Z = 11.964 Z = 9.941 Z = 2.578
Sigif. p < 0.0001 p < 0.0001 p < 0.0001 p < 0.0001 p < 0.0001 p < 0.005
- data not recorded at that site; 1 includes cocaine or crack as 1st, 2nd, 3rd or 4th substance of abuse; 2 distinction between cocaine and crack no longer recorded, have used mode as a proxy with 
"smoking" taken as indicative of crack cocaine use; 3 primary substance of abuse; 4 % new admissions among cocaine/crack patientsSubstance Abuse Treatment, Prevention, and Policy 2007, 2:37 http://www.substanceabusepolicy.com/content/2/1/37
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of crack cocaine to cocaine HCL is currently about two to
one in Cape Town and Gauteng, and more than four to
one in the Eastern Cape (Table 1).
In all sites the percentage of first time admissions among
patients having cocaine as a primary drug of abuse has fluc-
tuated between about 50% and 70% (Table 1). There has
been no discernable increase or decrease in this percentage
over time. Among patients who present for the treatment of
cocaine related problems, the main mode of cocaine HCL
administration is through snorting, and crack cocaine is
smoked. Across all sites less than one percent of patients
reported injecting cocaine. This has not changed over time.
In terms of the frequency of cocaine use, 65% of patients in
treatment in Cape Town with cocaine as a primary drug of
abuse in the second half of 2006 reported daily use, com-
pared to 45% in the Eastern Cape. A quarter of these
patients in Cape Town reported using cocaine between two
and six times per week compared to 41% in the Eastern
Cape. In the second half of 2006 the mean length of time
between the age of first treatment admission and age of first
use of cocaine was 3.4 years (SD = 4.68) in the Eastern Cape
and 6.1 years (SD = 5.25) in Cape Town. No data were
available on this for Gauteng.
The mean age at which patients with cocaine related prob-
lems present for treatment has remained between 29 and
32 years in Cape Town (overall mean = 29.9, SD = 0.86),
28 and 30 years in Gauteng (overall mean = 28.7, SD =
0.75), and 27 and 29 years in the Eastern Cape (overall
mean = 28.1, SD = 0.78). Table 2 shows that from 1997 to
2006 the percentage of persons seeking treatment for
cocaine related problems who were female has fluctuated
between 10% and 31% in Cape Town (overall mean =
21.8, SD = 4.55), between 14% and 28% in Gauteng
(overall mean = 20.6, SD = 3.82), and between 14% and
20% in the Eastern Cape (overall mean = 17.0, SD = 2.12).
In Cape Town the proportion of black African patients
having cocaine as a primary drug of abuse has been con-
sistently low (under 7%) whereas there has been an
increase in the proportion of cocaine patients who are
"Coloured" over time (Z = 4.003, p < 0.0001) (Table 2).
The latter has resulted from a decline in the proportion of
cocaine patients who are white. The terms "white",
"black", and "Coloured", originate from the Apartheid
era. They refer to demographic markers and do not signify
inherent characteristics. They refer to people of European,
African and mixed (African, European and/or Asian)
ancestry, respectively. Their continued use in South Africa
is important for monitoring improvements in health and
socio-economic disparities, identifying vulnerable sec-
tions of the population, and planning effective interven-
tions.
In Gauteng between the second half of 1999 and the sec-
ond half of 2006 roughly 60% or more patients having
cocaine as a primary drug of abuse were white (Table 2).
The Cochrane-Armitage trend test revealed that the pro-
portion of patients treated for cocaine related problem
who were black African in Gauteng increased significantly
from 4.8% in the second half of 1999 to 12.5% in the sec-
ond half of 2006 (Z = 5.364, p < 0.0001). Similarly there
was a significant increase in the proportion of cocaine
patients who were Coloured, from 8.8% to 18.7% (Z =
6.985, p < 0.0001). In the Eastern Cape there was also a
significant increase in the proportion of Coloured cocaine
patients, from 15.2% in the first half of 2004 to 43.5% in
the second half of 2006 (Z = 5.218, p < 0.0001). Likewise
the proportion of cocaine patients who were Coloured in
Cape Town increased significantly over the 20 reporting
periods from 3.6% to 31.1% (Z = 4.003, p < 0.0001).
Poly drug use is common. Table 3 shows for the second
half of 2006 for each site separately both the proportion
of other drugs that are secondary when cocaine is primary
as well as the primary drugs of abuse when cocaine is sec-
ondary. When cocaine is the primary drug of choice, it is
often used in conjunction with alcohol and with canna-
bis. In the Cape Town and the Eastern Cape the main
"sedative" drug used in combination with cocaine (when
primary) appears to be methaqualone (a sedative-hyp-
notic known locally as Mandrax), whereas in Gauteng it is
heroin. In Cape Town the main primary drug that was
reported when cocaine was secondary was methampheta-
mine (another stimulant), in Gauteng it was heroin (a
"downer") and in the Eastern Cape it was methaqualone
Percentage of patients from specialist treatment centres in  Cape Town, Gauteng and the Eastern Cape reporting that  cocaine was a primary, secondary, tertiary or fourth drug of  abuse, January 1997 to December 2006 (by 6-month period) Figure 1
Percentage of patients from specialist treatment centres in 
Cape Town, Gauteng and the Eastern Cape reporting that 
cocaine was a primary, secondary, tertiary or fourth drug of 
abuse, January 1997 to December 2006 (by 6-month period).
97a refers to the first half of 1997, 97b refers to the second half of 1997,etc.
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(a sedative). A number of secondary cocaine users in all
sites used heroin as primary drugs of abuse. In Cape Town
methamphetamine also featured prominently.
Discussion
Findings from SACENDU indicate that over time cocaine
use has placed an increased burden on AOD treatment
services in several provinces in South Africa, though some
inter-site variation is occurring. This increase has not been
constant and at times cocaine related treatment admis-
sions have even shown a decline. The drop off in cocaine
related treatment admissions in Cape Town and Gauteng
in the second half of 1999 and the subsequent increase
might be linked to changes in global cocaine production
over that time period [14]. In all sites reported on in this
paper, treatment admissions related to cocaine use have
increased over time, but the current rate of increase
appears to be much higher in the Eastern Cape than in
Gauteng and Cape Town. There have been no systematic
changes in the provision of treatment services or admis-
sions policies that could explain these findings. Discus-
sions with community sources and the police indicate that
Table 2: Gender and racial profile of patients with cocaine (HCL/crack) as their primary drug of abuse: 1997–2006
Cape Town Gauteng Eastern Cape
Period Fem. Black 
Afr.
Colou
red
Asian White Fem. Black 
Afr.
Colou
red
Asian White Fem. Black 
Afr.
Colou
red
Asian White
1 9 9 7 a 1 9 . 7 0 . 0 3 . 6 7 . 1 8 9 . 3 ----------
1 9 9 7 b 3 1 . 2 2 . 3 2 5 . 6 2 . 3 6 9 . 8 ----------
1 9 9 8 a 2 0 . 6 1 . 4 2 3 . 9 2 . 8 7 1 . 8 1 7 . 8 ---------
1 9 9 8 b 2 0 . 2 5 . 1 1 7 . 0 1 . 7 7 6 . 3 1 7 . 2 ---------
1 9 9 9 a 2 2 . 0 1 . 3 3 2 . 9 2 . 5 6 3 . 3 2 4 . 0 ---------
1999b 19.1 1.3 38.2 13.2 47.4 23.4 4.8 8.8 12.8 73.6 - - - - -
2000a 9.8 0.9 51.9 4.6 42.6 17.2 3.8 9.3 12.8 73.7 - - - - -
2000b 19.2 0.0 38.8 2.0 59.2 19.7 8.0 7.6 13.1 69.2 - - - - -
2001a 25.0 2.6 29.3 4.3 63.8 19.5 6.2 8.6 8.6 76.6 - - - - -
2001b 19.3 1.1 43.7 5.7 49.4 23.2 7.7 12.9 9.0 70.3 - - - - -
2002a 20.8 5.8 29.1 5.8 59.2 27.9 4.9 7.7 9.8 77.6 - - - - -
2002b 28.8 1.0 32.4 5.9 60.8 17.1 10.3 8.2 10.3 71.2 - - - - -
2003a 18.3 1.5 37.0 11.9 49.6 27.1 7.7 7.1 8.4 76.8 - - - - -
2003b 19.6 6.6 45.6 2.9 44.9 22.0 10.4 8.8 10.4 70.4 - - - - -
2004a 21.0 3.7 42.8 4.2 49.3 18.0 9.4 15.6 7.4 67.6 18.2 3.0 15.2 12.1 69.7
2004b 22.4 2.4 40.3 3.9 53.4 22.4 9.2 14.1 5.3 71.1 14.3 4.8 28.6 2.4 64.3
2005a 24.6 2.0 46.6 4.9 45.6 21.0 8.5 19.6 6.6 65.3 15.1 5.5 32.9 5.5 56.2
2005b 27.6 3.7 47.2 1.2 47.9 23.3 11.5 20.6 3.5 64.4 17.0 1.9 34.0 3.8 60.4
2006a 25.2 4.5 38.5 3.8 53.2 13.6 12.8 16.2 7.8 63.2 20.2 2.4 34.7 6.5 56.5
2006b 21.1 3.8 31.1 6.1 59.1 17.0 12.5 18.7 9.1 59.8 16.9 3.2 43.5 6.5 46.8
Table 3: Proportion of selected other drugs abused with cocaine as primary and secondary drug of abuse (2006b)
Cape Town Gauteng Eastern Cape
Cocaine as 
primary drug: 
Other drugs
Drugs that are 
primary when 
cocaine is 
secondary
Cocaine as 
primary drug: 
Other drugs
Drugs that are 
primary when 
cocaine is 
secondary
Cocaine as 
primary drug: 
Other drugs
Drugs that are 
primary when 
cocaine is 
secondary
None 30.6 N/A 36.5 N/A 41.1 N/A
Alcohol 37.3 26.8 29.2 25.4 25.8 18.6
Cannabis 26.9 13.2 23.2 20.4 29.0 32.6
Methaqualone 12.7 3.4 3.7 2.6 18.5 11.6
Heroin 6.0 18.5 10.5 35.0 5.7 20.9
Ecstasy 6.0 1.5 6.2 1.5 7.3 7.0
Methamphetamine 11.9 33.7 0.6 0.5 1.6 7.0
Methcathinone 0.8 1.0 4.0 13.1 0 1.6
OTC-Prescription 
medicines
6.7 1.5 4.8 1.5 1.6 2.3Substance Abuse Treatment, Prevention, and Policy 2007, 2:37 http://www.substanceabusepolicy.com/content/2/1/37
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the increase in cocaine related admissions in the Eastern
Cape is mainly due to the recent emergence of the cocaine
trade in Port Elizabeth and East London and the very
aggressive marketing practices accompanying it. If only
national data had been reported on, local variations such
as those recently experienced in the Eastern Cape and in
Cape Town would have disappeared.
The overall increase in cocaine related treatment admis-
sions over time has been accompanied by a reduction in
treatment admissions for other drugs of abuse with
depressant qualities, specifically alcohol and meth-
aqualone [15]. It has also been accompanied by an
increase in admissions for a broad range of other stimu-
lants including methamphetamine (in Cape Town) and
methcathinone (in Gauteng) [15]. A similar rise in treat-
ment admissions related to cocaine use was indicated in
the 2007 Annual Report of the EMDCCA on trend data for
1999 through 2005, increasing from 11% to 24% of new
drug clients during this period [18]. In contrast, in the
USA there appears to have been a steady fall off in cocaine
related treatment admissions since the mid 1990s, accom-
panied by a rise in problems related to other stimulants
and opiates [16]. The recent decline in cocaine related
treatment admissions in Cape Town is in all likelihood
also due to the increase in treatment admissions related to
another stimulant, methamphetamine [17]. In both
South Africa and the European Union, the majority of
patients coming to treatment with cocaine as a primary
drug of abuse are new admissions. In the absence of other
systemic changes, this may reflect an increasing incidence
of cocaine related problems.
In order to form effective prevention and treatment pro-
grammes the demographic profile of cocaine users needs
to be identified. Persons in treatment for cocaine for the
first time across the three South African sites are aged
between 27 and 32 years and are generally older than
individuals with problems related to other drugs [9]. They
generally started using cocaine three to five years prior to
treatment. Similar findings were reported by the
EMCDDA, where in 2004 the mean age for new patients
entering outpatient treatment for cocaine was 31 years for
males and 28 years for females. They were also reported as
being typically older than other drug consumers, apart
from users of hypnotics and sedatives, who are the oldest
even if figures are low [18]. In the USA the average age of
primary cocaine admissions was 38 years for smoked
cocaine and 34 years for non-smoked cocaine [16]. The
older age of cocaine patients may have implications for
issues that will need to be addressed during treatment,
such as a greater focus on the effect of their drug use on
partners, children and work than perhaps would be
needed for patients in their late teens and early twenties.
Substantially more males than females accessed treatment
for cocaine problems. The male to female ratio for
patients entering outpatient treatment for cocaine as a pri-
mary drug of abuse in 15 European countries in 2004 was
5.7:1 [18] which is fairly similar to what was found in this
study.
Rather than reflecting lower levels of cocaine use among
women, this may partly reflect gender differences in access
to treatment [19]. There seems to be a greater stigma asso-
ciated with drug dependence in females, and the abuse of
illicit drugs tends to remain hidden. In addition, women
in South Africa often do not have an independent income
to pay for treatment. Nevertheless, about 10%–30% of
persons treated for cocaine abuse are female.
Furthermore, the data suggest an increase in cocaine
related treatment admissions by Coloureds in all three
sites and by black Africans in Gauteng. In the 1990s drug
markets in South Africa were clearly segmented along
racial lines, with drugs like cocaine being marketed to
whites who tended to be more affluent [20]. Since 2000,
these markets have become less segmented, as reflected in
the aforementioned demographic shifts. The changes over
time cannot be explained in terms of systematic changes
in service delivery that might have increased access by par-
ticular population groups. The likely reason that black
Africans are not showing up in greater numbers at drug
treatment centres in the Eastern Cape is probably due to
the substantially higher levels of poverty [3] which has
meant that black Africans in this province tend to abuse
alcohol and cannabis rather than more expensive sub-
stances, as well as the limited number of treatment slots in
the affordable, non-profit treatment sector. Lower utilisa-
tion of drug treatment services for cocaine and other drug
problems by black Africans in Cape Town and Gauteng
could also be due to the fact that the majority of black
Africans still reside in suburbs far from drug treatment
and other services [21].
In contrast to Europe where more than 80% of new out-
patients with cocaine problems report using cocaine
hydrochloride [18], in South Africa the most prominent
mode of cocaine consumption reported by persons com-
ing to drug treatment is crack cocaine (65% to 84% in the
three sites currently). Treatment data from the USA also
indicates high levels of crack cocaine usage (72% in
2005). There are indications that the use of cocaine in this
form increases sexual risk behaviour and is related to lev-
els of violence [22,23]; although these associations could
also be partially explained by contextual factors such as
crowding. The growing use of crack cocaine is of great con-
cern to a country like South Africa where sexual risk
behaviour and interpersonal violence together contribute
40% of the total burden of death and disability in theSubstance Abuse Treatment, Prevention, and Policy 2007, 2:37 http://www.substanceabusepolicy.com/content/2/1/37
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country [24]. With high levels of patients reporting daily
use of cocaine (e.g. 65% of patients in Cape Town) this is
an added concern. With regard to mode of use, roughly
70% of patients in treatment reported smoking their
cocaine with the remainder mostly snorting/sniffing.
Smoking is an extremely potent and direct form of admin-
istration. In contrast, EMCDDA treatment data for 2005
reported that 53% of patients in treatment reported snort-
ing or sniffing the substance, 34% smoking it and 5%
injecting [18]. Fortunately less than one percent of
patients in the South African study reported injecting
cocaine, thus decreasing their risk of contracting injection-
related HIV or Hepatitis B/C.
In responding to the threat of cocaine use in South Africa
it is important to remember that poly-drug use is high. In
roughly two-thirds of cases where cocaine was the primary
drug of abuse other drugs were reported as secondary, typ-
ically alcohol and cannabis. Similar secondary drugs were
reported by the EMCDDA with the addition of heroin
[18]. Conversely, in Gauteng and the Eastern Cape a high
proportion of patients having heroin as a primary drug of
abuse had cocaine as a secondary drug. Treatment plan-
ning needs to take into account such poly-drug use.
According to the most recent European data a diversifica-
tion of cocaine users in treatment can be identified. Three
main groups are seen, (i) users of cocaine powder often
combined with alcohol and/or cannabis, (ii) users of
crack cocaine with other drugs and/or heroin, and (iii)
polydrug users, consuming cocaine and heroin [18].
While political attention in South Africa has been given
increasingly to problems related to methamphetamine
and heroin use, very little attention has been directed to
cocaine abuse despite the fact that roughly one in five
patients coming to drug treatment currently has cocaine as
a primary or secondary drug of abuse. One of the policy
implications of this research is that substance abuse prac-
titioners need to be trained in and provided with specific
treatment protocols for addressing cocaine and other
stimulant related problems. Such protocols and training
are lacking in South Africa. The increasing levels of
cocaine related treatment admissions in Gauteng and the
Eastern Cape also highlight the importance of addressing
gaps in supply reduction and ensuring that universal and
selected prevention programmes take cognisance of par-
ticular issues related to cocaine use. Prevention efforts
need to focus on persons who have not used any drugs as
well as persons in their early twenties who might be using
other drugs. Given the ongoing rise in use of cocaine
among Coloured and black African populations, preven-
tion efforts need to be sensitive to pressures to use cocaine
among these population groups and in communities
where they tend to reside.
The main limitation of this study is that treatment data are
affected by the lack of available treatment options for drug
abuse in South Africa, particularly for the most disadvan-
taged sectors of society [21]. This limitation highlights the
need for further community-based studies such as school
surveys, key informant and user interviews to assess the
use of the drug in populations that might not have access
to specialist substance abuse treatment or who might be
accessing other services such as private mental health pro-
fessionals and other kinds of support services. While we
controlled for double counting of patents within a treat-
ment centre we were not able to control for double count-
ing across centres. This may have slightly inflated the
number of patients receiving treatment and may have
biased the data towards those patients who seek treatment
across more than one institution. Another limitation of
the study is that not all the patients would necessarily
have met the criteria for cocaine dependence. Further
research is therefore required that would investigate the
severity of the problems experienced by patients seeking
treatment for cocaine problems. A further limitation of
this study comes from the fact that data were only
reported on three sites. It is possible that other patterns of
cocaine use exist in other areas. With the expansion of
SACENDU to all provinces in 2007/8, this shortcoming
will be addressed.
Conclusion
In South Africa, as in Europe, there has been a substantial
increase in cocaine related treatment admissions over
time. In the second half of the 1990s cocaine users enter-
ing treatment tended to be white males who preferred to
smoke the substance. Treatment admissions were tradi-
tionally higher in large urban centres like Cape Town and
Pretoria/Johannesburg (Gauteng province). In recent
years, a partial shift in this profile has occurred, with use
increasing in less economically strong areas like the East-
ern Cape, and among black African and especially Col-
oured users. These emerging trends point to the
possibility of cocaine use becoming a serious health and
social issue in South Africa and demonstrate the need for
continued monitoring of cocaine treatment admissions in
the future (especially given the dearth of any other ongo-
ing monitoring systems) and demonstrate the need to
address cocaine use in national and provincial policy
planning and intervention efforts.
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